Larry G. Edwards La Jolla Pharmaceutical CO (LJPC) insider trading activity

LJPC Quotes by TradingView

Larry G. Edwards is Chief Executive Officer of LA JOLLA PHARMACEUTICAL CO. Currently has a direct ownership of 0 shares of LJPC, which is worth approximately $0. The most recent transaction as insider was on Aug 22, 2022, when has been sold 11,969 shares (Common Stock) at a price of $6.23 per share, resulting in proceeds of $74,567. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Larry G. Edwards Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 22 2022
SELL
Sale (or disposition) back to the issuer
$74,567 $6.23 p/Share
11,969 Reduced 100.0%
0 Common Stock
Apr 14 2022
BUY
Grant, award, or other acquisition
$1,098 $3.71 p/Share
296 Added 2.41%
11,969 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
$1,212 $3.63 p/Share
334 Added 2.78%
11,673 Common Stock
Mar 15 2022
BUY
Grant, award, or other acquisition
$1,217 $3.37 p/Share
361 Added 3.09%
11,339 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
$1,218 $3.48 p/Share
350 Added 3.09%
10,978 Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
$1,213 $3.79 p/Share
320 Added 2.92%
10,628 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
$16,430 $3.94 p/Share
4,170 Added 28.8%
10,308 Common Stock
Jan 14 2022
BUY
Grant, award, or other acquisition
$1,141 $4.18 p/Share
273 Added 4.26%
6,138 Common Stock
Dec 30 2021
BUY
Grant, award, or other acquisition
$913 $3.92 p/Share
233 Added 3.82%
5,865 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
$1,146 $3.58 p/Share
320 Added 5.38%
5,632 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
$1,145 $3.31 p/Share
346 Added 6.12%
5,312 Common Stock
Nov 15 2021
BUY
Grant, award, or other acquisition
$1,146 $3.41 p/Share
336 Added 6.34%
4,966 Common Stock
Oct 29 2021
BUY
Grant, award, or other acquisition
$1,146 $3.42 p/Share
335 Added 6.75%
4,630 Common Stock
Oct 15 2021
BUY
Grant, award, or other acquisition
$1,149 $3.37 p/Share
341 Added 7.36%
4,295 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
$1,146 $3.39 p/Share
338 Added 7.88%
3,954 Common Stock
Sep 15 2021
BUY
Grant, award, or other acquisition
$1,146 $3.39 p/Share
338 Added 8.55%
3,616 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
$1,146 $3.58 p/Share
320 Added 8.89%
3,278 Common Stock
Aug 13 2021
BUY
Grant, award, or other acquisition
$1,142 $3.38 p/Share
338 Added 10.25%
2,958 Common Stock
Jul 30 2021
BUY
Grant, award, or other acquisition
$1,148 $3.07 p/Share
374 Added 12.49%
2,620 Common Stock
Jul 15 2021
BUY
Grant, award, or other acquisition
$1,146 $3.2 p/Share
358 Added 13.75%
2,246 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$1,147 $3.64 p/Share
315 Added 14.3%
1,888 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
$1,147 $4.17 p/Share
275 Added 14.88%
1,573 Common Stock
May 28 2021
BUY
Grant, award, or other acquisition
$1,146 $3.65 p/Share
314 Added 19.48%
1,298 Common Stock
May 14 2021
BUY
Grant, award, or other acquisition
$1,146 $3.2 p/Share
358 Added 26.68%
984 Common Stock
Apr 30 2021
BUY
Grant, award, or other acquisition
$1,146 $3.77 p/Share
304 Added 32.69%
626 Common Stock
LGE

Larry G. Edwards

Chief Executive Officer
Waltham, MA

Track Institutional and Insider Activities on LJPC

Follow LA JOLLA PHARMACEUTICAL CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LJPC shares.

Notify only if

Insider Trading

Get notified when an La Jolla Pharmaceutical CO insider buys or sells LJPC shares.

Notify only if

News

Receive news related to LA JOLLA PHARMACEUTICAL CO

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LJPC